Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

Similar articles for PubMed (Select 22734595)

1.

Patterns of failure after multimodal treatments for high-grade glioma: effectiveness of MIB-1 labeling index.

Uehara K, Sasayama T, Miyawaki D, Nishimura H, Yoshida K, Okamoto Y, Mukumoto N, Akasaka H, Nishihara M, Fujii O, Soejima T, Sugimura K, Kohmura E, Sasaki R.

Radiat Oncol. 2012 Jun 26;7:104. doi: 10.1186/1748-717X-7-104.

2.

MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.

Neder L, Colli BO, Machado HR, Carlotti CG Jr, Santos AC, Chimelli L.

Clin Neuropathol. 2004 Nov-Dec;23(6):262-70.

PMID:
15584210
3.

Solitary fibrous tumor of the central nervous system: a clinicopathologic study of 24 cases.

Chen H, Zeng XW, Wu JS, Dou YF, Wang Y, Zhong P, Xu R, Jiang CC, Wang XQ.

Acta Neurochir (Wien). 2012 Feb;154(2):237-48; discussion 248. doi: 10.1007/s00701-011-1160-9. Epub 2011 Sep 22.

PMID:
21938461
4.

Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.

Ralte AM, Sharma MC, Karak AK, Mehta VS, Sarkar C.

Pathol Oncol Res. 2001;7(4):267-78.

5.
6.

Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma.

Nakamura M, Konishi N, Tsunoda S, Hiasa Y, Tsuzuki T, Inui T, Sakaki T.

Cancer. 1997 Jul 15;80(2):242-9.

PMID:
9217037
7.

MIB-1 labeling index predicts recurrence in intraventricular central neurocytomas.

Kaur G, Kane AJ, Sughrue ME, Oh M, Safaee M, Sun M, Tihan T, McDermott MW, Berger MS, Parsa AT.

J Clin Neurosci. 2013 Jan;20(1):89-93. doi: 10.1016/j.jocn.2012.05.025. Epub 2012 Nov 5.

8.

A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma.

Pan E, Yu D, Yue B, Potthast L, Chowdhary S, Smith P, Chamberlain M.

J Neurooncol. 2012 Oct;110(1):111-8. doi: 10.1007/s11060-012-0943-z. Epub 2012 Jul 26.

PMID:
22832897
9.

MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.

Korkolopoulou P, Christodoulou P, Kouzelis K, Hadjiyannakis M, Priftis A, Stamoulis G, Seretis A, Thomas-Tsagli E.

Br J Cancer. 1997;75(9):1269-78.

10.

Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution.

Ogura K, Mizowaki T, Arakawa Y, Ogura M, Sakanaka K, Miyamoto S, Hiraoka M.

Radiat Oncol. 2013 Apr 23;8:97. doi: 10.1186/1748-717X-8-97.

11.

Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series.

Rusthoven KE, Olsen C, Franklin W, Kleinschmidt-DeMasters BK, Kavanagh BD, Gaspar LE, Lillehei K, Waziri A, Damek DM, Chen C.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):211-7. doi: 10.1016/j.ijrobp.2010.04.069. Epub 2010 Aug 21.

PMID:
20732762
12.

MIB-1 labeling index in nonpilocytic astrocytoma of childhood: a study of 101 cases.

Ho DM, Wong TT, Hsu CY, Ting LT, Chiang H.

Cancer. 1998 Jun 15;82(12):2459-66.

PMID:
9635540
13.

Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.

Oya S, Kawai K, Nakatomi H, Saito N.

J Neurosurg. 2012 Jul;117(1):121-8. doi: 10.3171/2012.3.JNS111945. Epub 2012 May 4. Erratum in: J Neurosurg. 2012 Oct;117(4):806.

PMID:
22559847
14.

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.

Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, Faivre C, Huart J, Lotz JP, Antoine M, Pène F, Blondon J, Izrael V, Laugier A, Schlienger M, Housset M.

Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):25-38.

PMID:
9989511
15.

Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.

Cuneo KC, Vredenburgh JJ, Sampson JH, Reardon DA, Desjardins A, Peters KB, Friedman HS, Willett CG, Kirkpatrick JP.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2018-24. doi: 10.1016/j.ijrobp.2010.12.074. Epub 2011 Apr 12.

16.

Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy.

Grabenbauer GG, Mühlfriedel C, Rödel F, Niedobitek G, Hornung J, Rödel C, Martus P, Iro H, Kirchner T, Steininger H, Sauer R, Weidenbecher M, Distel L.

Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1041-50.

PMID:
11072161
17.

Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.

Pollack IF, Hamilton RL, Burnham J, Holmes EJ, Finkelstein SD, Sposto R, Yates AJ, Boyett JM, Finlay JL.

Neurosurgery. 2002 Jun;50(6):1238-44; discussion 1244-5.

PMID:
12015841
18.

The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.

Roser F, Samii M, Ostertag H, Bellinzona M.

Acta Neurochir (Wien). 2004 Jan;146(1):37-44; discussion 44. Epub 2003 Dec 22.

PMID:
14740263
19.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
20.

Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.

Shapiro LQ, Beal K, Goenka A, Karimi S, Iwamoto FM, Yamada Y, Zhang Z, Lassman AB, Abrey LE, Gutin PH.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):636-42. doi: 10.1016/j.ijrobp.2012.05.031. Epub 2012 Jul 3.

PMID:
22765876
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk